News from pdl biopharma, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 15, 2014, 16:02 ET

PDL BioPharma Completes Regular Quarterly Dividend Payment

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the December 12, 2014, regular quarterly dividend payment of $0.15...

Dec 10, 2014, 16:02 ET

PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced revenue guidance for the fourth quarter ending December 31, 2014, of approximately...

Dec 04, 2014, 16:01 ET

PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the: - 3.75% Convertible Senior Notes...

Nov 18, 2014, 07:00 ET

PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that in connection with the acquisition of Durata Therapeutics, Inc. by Actavis, PDL has...

Nov 14, 2014, 07:00 ET

PDL BioPharma Announces Successful Conclusion of Revenue Interest Agreement with AxoGen

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company has received $30.3 million, in addition to previously received...

Nov 12, 2014, 07:00 ET

PDL BioPharma to Present at Jefferies 2014 Global Healthcare Conference

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that company management will present at the Jefferies 2014 Global Healthcare...

Nov 10, 2014, 16:02 ET

PDL BioPharma Announces Third Quarter 2014 and Year to Date Financial Results

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the third quarter and nine months ended September 30, 2014....

Nov 06, 2014, 16:02 ET

PDL BioPharma Acquires a Portion of the University of Michigan's Royalty Interest in Genzyme's Cerdelga™ (eliglustat) Capsules for $65.6 Million

 PDL BioPharma ("PDL") (Nasdaq: PDLI) announced today that it has acquired a portion of the University of Michigan's ("U-M") worldwide royalty...

Nov 03, 2014, 16:02 ET

PDL BioPharma to Announce Third Quarter 2014 Financial Results on November 10, 2014

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its third quarter 2014 financial results for the period...

Oct 08, 2014, 09:00 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL Announces Appointment of PricewaterhouseCoopers LLP as its New Independent Registered Public Accounting Firm

 PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI), today announced the appointment of PricewaterhouseCoopers LLP ("PwC") as its...

Oct 06, 2014, 07:00 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Bolsters Management Team

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI), today announced two enhancements to the company's management team.  Danny Hart, who has served...

Sep 23, 2014, 09:00 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Responds to Class Action Lawsuit

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI), has been informed of a class action lawsuit filed against the company that alleges violations of...

Sep 17, 2014, 17:57 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) was orally notified by its independent registered accounting firm, Ernst & Young LLP ("EY") that...

Sep 15, 2014, 12:05 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Completes Regular Quarterly Dividend Payment

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the September 12, 2014, regular quarterly dividend payment of...

Sep 09, 2014, 16:01 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Provides Third Quarter 2014 Revenue Guidance of $165 Million

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced revenue guidance for the third quarter ending September 30, 2014, of...

Sep 04, 2014, 16:02 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the: -  3.75% Convertible Senior...

Aug 18, 2014, 16:09 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Announces Second Quarter 2014 and Year to Date Financial Results

  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the second quarter and six months ended June 30,...

Aug 18, 2014, 07:00 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Announces Plans to Issue Second Quarter Financial Results After Market Today and Reschedules Earnings Call for Tuesday, August 19 at 4:30pm EDT

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will issue its second quarter financial results after market today and...

Aug 08, 2014, 15:20 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Announces Delay in Filing Quarterly Report on Form 10-Q

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company has filed a Form 12b-25 Notification of Late Filing with the U.S....

Jul 30, 2014, 07:00 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that company management will participate in the Jefferies 2014 Boston Healthcare...